Robert Spurr, U.S. President-Pharma Business at Bausch Health Companies Inc. (BHC), sold 9,692 shares at $22.20 ($215K) on 2022-03-15, disclosed to the SEC on 2022-03-16.
Open-market sale of $215k BHC by U.S. President-Pharma Business. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.20 | 4,846 | $108K | 50.0% |
| 2 | $22.20 | 4,846 | $108K | 50.0% |
| Total | $22.20 avg | 9,692 | $215K | 100% |
| Filing → |
| BHC | SELL | 2022-02-17 | $163K | — | Filing → |
| BHC | SELL | 2022-01-20 | $173K | — | Filing → |